fbpx

IAOMT logo Dental Mercury Regulatory


Minamata Convention on Mercury

In August of 2017, the United Nations Environment Programme (UNEP)’s Minamata Convention on Mercury entered into force. The Minamata Convention is a global treaty to protect human health and the environment from the adverse effects of mercury, and it includes sections on dental amalgam. The IAOMT is an accredited member of member of UNEP’s Global [...]

Minamata Convention on Mercury2018-01-19T15:38:44+00:00

EPA Dental Effluent Guidelines

The US Environmental Protection Agency (EPA) updated their dental effluent guidelines in 2017. Amalgam separators are now required pretreatment standards to reduce discharges of mercury from dental offices into publicly owned treatment works (POTWs).  EPA expects compliance with this final rule will annually reduce the discharge of mercury by 5.1 tons as well as 5.3 [...]

EPA Dental Effluent Guidelines2018-01-19T17:00:13+00:00

The European Commission 2014 Opinion on Environmental Risks of Dental Amalgam

  Final Opinion on Environmental risks and indirect health effects of mercury from dental amalgam (update 2014) The European Commission and its non-food Scientific Committee on Health and Environmental Risks (SCHER) published the final opinion on Environmental risks and indirect health effects of mercury from dental amalgam, of which the aim was to update the [...]

The European Commission 2014 Opinion on Environmental Risks of Dental Amalgam2018-01-19T16:59:20+00:00

Predicting the Future of Dental Amalgam Use and FDA Regulation

By Michael D. Fleming, DDS This article was published in the February 2013 edition of "DentalTown" Magazine There is a no greater challenge in dentistry these days than accurately predicting the future of dental amalgam use and FDA regulation. Given the more restrictive trends in federal and international regulatory policy with respect to mercury in [...]

Predicting the Future of Dental Amalgam Use and FDA Regulation2018-01-19T16:56:48+00:00

The Real Cost of Dental Mercury

This 2012 report confirms that “amalgam is by no means the least expensive filling material when the external costs are taken into account.” It was co-released by the IAOMT and Concorde East/West Sprl, the European Environmental Bureau, the Mercury Policy Project, the International Academy of Oral, Clean Water Action and Consumers for Dental Choice. Click [...]

The Real Cost of Dental Mercury2018-01-19T16:43:04+00:00

Text of FDA’s Actual 2012 Amalgam Safety Proposal

In January 2012, the FDA had actually prepared a "Safety Communication" that recommended reducing the use of mercury amalgam in the general population, and avoiding it in susceptible sub-populations: pregnant and nursing women children under six years of age people with allergy to mercury or other components people with neurological disease people with [...]

Text of FDA’s Actual 2012 Amalgam Safety Proposal2018-09-29T18:15:45+00:00

The US Amalgam Debate

This paper, written by engineer Robert Cartland, who testified about his own experiences with mercury toxicity at the December, 2010, FDA hearings, is a very thorough, deeply researched look at the issues under debate concerning dental amalgam. View Article: Cartland -US Dental Amalgam Debate 2010 FDA Meeting 2012-11-18

The US Amalgam Debate2018-01-19T16:27:45+00:00

Amalgam Risk Assessments 2010

On December 14 and 15, 2010, the FDA convened a scientific panel to re-examine the issue of mercury exposure from amalgam dental fillings. Two private foundations, assisted by IAOMT, commissioned G. Mark Richardson, PhD, of SNC Lavallin, Ottawa, Canada, formerly of Health Canada, to provide the scientific panel and FDA regulators with a formal risk [...]

Amalgam Risk Assessments 20102018-01-19T16:26:16+00:00

IAOMT-Sponsored Petition to Reverse FDA Classification of Amalgam

The 2009 IAOMT prepared the attached petition for a group of citizens as part of an effort to use all available legal means to overturn the FDA's classification of dental amalgam as a Class II device. The thrust of the petition is found in this quote: "We have no doubt that the FDA has the [...]

IAOMT-Sponsored Petition to Reverse FDA Classification of Amalgam2018-01-19T16:25:07+00:00